GlassScriptPhysician profile
Darin C Leslie
NPI 1477608099
$949.64
in general payments reported to CMS, 2019-2025
16 companies · $211 in 2025
The $211 reported for 2025 was less than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $184 · 2022: $93.95 · 2023: $308 · 2024: $152 · 2025: $211.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $672.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $671.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $248.36 | 2022-2025 | Azstarys |
| Ironshore Pharmaceuticals INC. | $122.26 | 2021-2024 | Jornay Pm |
| Supernus Pharmaceuticals, INC. | $86.35 | 2022-2025 | Qelbree, Qelbree |
| Sanofi-Aventis U.S. LLC | $61.95 | 2023-2025 | |
| Pfizer INC. | $61.57 | 2021-2025 | |
| Sobi, INC | $59.98 | 2021-2023 | |
| Tris Pharma INC | $54.06 | 2021 | |
| Quidel Corporation | $51.29 | 2021 | |
| Merck Sharp & Dohme LLC | $47.29 | 2021-2025 | Vaxneuvance, Gardasil 9, Vaxelis |
| Cranial Technologies, INC | $38.18 | 2021-2024 | Doc Band |
| Collegium Pharmaceutical, INC. | $24.81 | 2025 | Jornay Pm |
| Biomarin Pharmaceutical INC. | $20.72 | 2022 | |
| Sanofi Pasteur INC. | $19.80 | 2025 | |
| Seqirus USA INC | $19.76 | 2025 | Flucelvax |
| Acadia Pharmaceuticals INC | $19.76 | 2023 | Daybue |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amphastar Pharmaceuticals, INC. | $13.50 | 2024 | Baqsimi |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Darin Leslie listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.